Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MapLight Therapeutics, Inc.MPLT · Entity 5316 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MapLight Therapeutics, Inc.
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Voting Common StockSEC Table I · non-derivative | Direct | 53,457 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 3,932 · Balance 53,457 F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.64 · Expires 2036-06-22 | Direct | 14,902 |
Reported balance
After 2026-06-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-23 · Grant · Acquired 14,902 · Balance 14,902 F4: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. |
| Voting Common StockSEC Table I · non-derivative | IndirectSee footnote | 14,124 |
Reported balance
Holding disclosure · report date 2026-06-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 14,124 F3: The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
F3: The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power.
F4: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 21:59 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001998937-26-000004 · form4-06252026_090607.xml · derivative · entry 3 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F4 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:59 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001998937-26-000004 · form4-06252026_090607.xml · nonDerivative · entry 1 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,457 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 22:45 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | PurchaseVoting Common Stock | 14,124 | $17.89 | $252,678.36 |
DisclosureSEC source: 0001998937-26-000002 · form4-02122026_050203.xml · nonDerivative · entry 1 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 14,124 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.76 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:15 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantEmployee Stock Option (right to buy) · Derivative | 25,604 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001998937-25-000006 · form4-10282025_041020.xml · derivative · entry 2 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,604 Underlying: Voting Common Stock · 25,604 shares Expires 2035-10-26 F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:15 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantVoting Common Stock | 6,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001998937-25-000006 · form4-10282025_041020.xml · nonDerivative · entry 1 Garnett Timothy John · CIK 0001998937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,294 F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.